Referred to the House Committee on Energy and Commerce.
Creates a Cancer Research Trust Fund in the Treasury funded by an amount equal to 10% of gross import duties on tobacco and tobacco substitute articles each fiscal year. The Treasury transfers amounts on request to HHS, which (coordinating with the Secretary of War acting through the Director of the Defense Health Agency) must use funds for R&D into early screening, prevention, treatments, and innovative therapies, prioritizing rare cancers and pediatric cancers.
Size and stability of funding: adequate versus too small or volatile
Relative to its intended legislative type, this bill creates a clear substantive funding mechanism (a Treasury trust fund funded by 10% of specified import duties) and identifies agency roles and high-level program priorities, but it provides limited implementation detail, fiscal treatment, statutory integration, safeguards, and accountability provisions.
Creates a Cancer Research Trust Fund in the Treasury funded by an amount equal to 10% of gross import duties on tobacco and tobacco substitute articles each fiscal year.
The Treasury transfers amounts on request to HHS, which (coordinating with the Secretary of War acting through the Director of the Defense Health Agency) must use funds for R&D into early screening, prevention, treatments, and innovative therapies, prioritizing rare cancers and pediatric cancers.
Moderate likelihood: non-controversial policy and clear purpose help, but dedicated revenue routing and budget rules create uncertainty.
Relative to its intended legislative type, this bill creates a clear substantive funding mechanism (a Treasury trust fund funded by 10% of specified import duties) and identifies agency roles and high-level program priorities, but it provides limited implementation detail, fiscal treatment, statutory integration, safeguards, and accountability provisions.
Size and stability of funding: adequate versus too small or volatile
These are examples from the analysis, not a ranked list of the most-affected groups.
Size and stability of funding: adequate versus too small or volatile
Generally supportive because it directs dedicated revenue to cancer research and prioritizes rare and pediatric cancers.
Concerned the revenue stream may be too small or volatile and that broader equity and prevention measures could be stronger.
Cautiously favorable: creates a politically popular fund using a user-pays revenue source.
Wants clarity on expected funding scale, oversight, and interaction with existing NIH/NCI programs.
Mixed to mildly skeptical: supports cancer research in principle but wary of creating a new federal trust fund and diverting customs revenue.
Prefers efficient use and offsets for new spending.
Reached or meaningfully advanced
Reached or meaningfully advanced
Still ahead
Still ahead
Still ahead
Moderate likelihood: non-controversial policy and clear purpose help, but dedicated revenue routing and budget rules create uncertainty.
The bill has not accumulated any surfaced votes yet.
Size and stability of funding: adequate versus too small or volatile
Moderate likelihood: non-controversial policy and clear purpose help, but dedicated revenue routing and budget rules create uncertainty.
Relative to its intended legislative type, this bill creates a clear substantive funding mechanism (a Treasury trust fund funded by 10% of specified import duties) and identifies agency roles and high-level program prio…
Go beyond the headline summary with full stakeholder mapping, legislative design analysis, passage barriers, and lens-by-lens tradeoff breakdowns.